Barely Significant
← all phrases

nearly significant

3,288 sentences · 3,288 papers · 3,797 search hits before verification · confirmed specimen

Sighted at

p=0.0579p=0.06

Listed by Hankins, posted since · Hankins (2013) · Otte et al. (2022)

In the literature

This nearly significant improvement was observed both in the overall study population and specifically among participants with prediabetes after three months of supplementation with pasteurized A. muciniphila MucT.
ORs adjusted for individual factors and an ergonomic factor (manual handling of objects) showed that low job satisfaction, lack of support from supervisors, interpersonal stress at work, depression, somatic symptoms, and a family history of LBP with disability were significant risk factors, and previous sick leave a nearly significant risk factor, for development of persistent from mild LBP.
We built tables as follows: the dark-gray background stands for a lack of studies (no data); the gray background (with a slash included in cells) indicates an absence of significance; light gray indicates a “nearly significant” association (inverse or positive); all other data with a white background illustrate statistically significant associations (inverse or positive). 3.
Binary logistic regression analysis of the clinical and pathological data The variables that showed significant or nearly significant differences when comparing the two groups based on the positive or negative expression of CK7 by hepatocytes (Table 2 ) were analysed via binary logistic regression and included the following: AMA, AMA-M2, anti-gp210, TB, DB, ALP, gamma-glutamyl transferase (GGT), TA, fibrosis, interface activity and ductopenia grade.
In order to check whether this correlation could have been driven by the (nearly significant) discrepancy in the verbalizer scores reported by the two groups, a partial correlation, controlling for visual status, was performed.
Loss of form vision impairs spatial imagery.
Front Hum Neurosci · 2014 · PMC3958697
A multi-country study by Simpson-Yap et al., published as a pre-print, which included 2,340 MS patients with SARS-CoV-2 infection, identified an increased risk for hospitalization, ICU admission, and ventilator use with rituximab (OR, 2.43; 95% CI, 1.48–4.02; OR, 3.93; 95% CI, 1.56–9.89; OR, 4.00; 95% CI, 1.54–10.39, respectively) and an increased risk for hospitalization with ocrelizumab (OR, 1.56; 95% CI:, 1.01–2.41), when compared to dimethyl fumarate; the risk for ICU admission with ocrelizumab was nearly significant (OR, 2.30; 95%, 0.98–5.39).